Veterans have been dying from opioid addiction and PTSD for two decades while bureaucrats debated the paperwork.
One text message from Joe Rogan just moved faster than twenty years of federal bureaucracy.
Trump read it, picked up the phone, and by Saturday morning an executive order was sitting on the Oval Office desk – and the FDA's approach to psychedelic therapy was permanently changed.
How a Text Message Became an Executive Order
Rogan told Trump that ibogaine – a psychedelic compound derived from a West African shrub – was showing remarkable results treating opioid addiction and PTSD in veterans.
Trump's response came back almost instantly.
"The text message came back: 'Sounds great. Do you want FDA approval? Let's do it,'" Rogan said Saturday. "It was literally that quick."
The order directs the FDA to expedite breakthrough therapy designations for compounds including ibogaine and LSD, encourages interagency data sharing, and opens the door to rapid scheduling changes if safety and efficacy are demonstrated.
https://twitter.com/EricLDaugh/status/2045496872131846455?s=20
CMS Administrator Mehmet Oz described the internal effort as a policy sprint – officials moved in days to translate that exchange into a formal presidential directive.
The Veterans Who Have Been Waiting for This
Former Navy SEAL Marcus Luttrell stood next to Trump at the signing and said what the bureaucrats wouldn't.
"It absolutely changed my life for the better," Luttrell said of psychedelic therapy. "You're going to save a lot of lives through it."
Think about what that means coming from a man who watched his entire team get killed in Afghanistan and came home carrying that weight for years.
The VA gave him antidepressants and a hotline number.
Ibogaine gave him his life back.
Luttrell isn't alone.
Veterans groups and Republican lawmakers have pushed ibogaine specifically because existing treatments – antidepressants, talk therapy, endless medication management – have failed tens of thousands of men and women who came home from Iraq and Afghanistan in pieces.
More than 6,000 veterans die by suicide every year.
That number has barely moved despite two decades of VA budget increases, awareness campaigns, and federal mental health initiatives.
Trump looked at that record and decided a text from Joe Rogan deserved more action than two decades of bureaucratic reports.
He's not wrong.
What Washington Refused to Do for Twenty Years
Ibogaine has been a Schedule I controlled substance since 1970 – the same legal category as heroin, with no recognized medical use and no pathway to treatment.
Researchers who wanted to study it faced a regulatory wall that made serious clinical trials nearly impossible.
"It's been incredibly difficult to study ibogaine in the US because of its known cardiotoxicity," said Frederick Barrett of Johns Hopkins University. "If the executive order can pave the way for doing objective, scientific research with this compound, it would help us understand whether it is truly a better psychedelic therapy than others."
That's the medical establishment's version of "finally."
RFK Jr. had been working internally for months to build a framework for expanding access to alternative mental health treatments.
https://twitter.com/CollinRugg/status/2045521963544973818?s=20
The difference between months of internal discussions and a signed executive order was one text message and a president who actually responds.
Two states – Oregon and Colorado – had already legalized supervised psilocybin therapy at the state level, building a body of real-world evidence that Washington steadfastly ignored.
Trump just changed that calculus for the entire country.
The medical risks are real – ibogaine has been linked to serious cardiac complications, and no psychedelic compound has cleared the FDA approval process.
That's exactly why the research needs to happen.
Veterans who watched their brothers take their own lives aren't asking for guarantees.
They're asking for a chance.
Trump gave them one.
Sources:
- CJ Womack, "Joe Rogan reveals text to Trump that helped expedite federal review of psychedelics," Fox News, April 20, 2026.
- Frederick Barrett, Johns Hopkins University, quoted via PBS reporting cited in Fox News, April 20, 2026.
